Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Lischalk

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Particle Therapy|July 1, 2022
Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal BalloonsMatthew Forsthoefel, Ryan Hankins, Elizabeth Ballew, et al.
Cancers|May 14, 2022
Return to Work, Fatigue and Cancer Rehabilitation after Curative Radiotherapy and Radiochemotherapy for Pelvic Gynecologic CancerEva Meixner, Elisabetta Sandrini, Line Hoeltgen, et al.
Clinical and Translational Radiation Oncology|March 6, 2023
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroidsEva Meixner, Juliane Hörner-Rieber, Jonathan W Lischalk, et al.
Radiation Oncology (London, England)|October 28, 2015
Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastasesJonathan W Lischalk, Eric Oermann, Sean P Collins, et al.
Frontiers in Oncology|April 24, 2023
Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failureJustin Leu, Meredith Akerman, Christopher Mendez, et al.
Frontiers in Oncology|March 15, 2021
Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate CancerNima Aghdam, Michael Carrasquilla, Edina Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 30, 2022
Iatrogenic influence on prognosis of radiation-induced contrast enhancements in patients with glioma WHO 1-3 following photon and proton radiotherapyTanja Eichkorn, Jonathan W Lischalk, Elisabetta Sandrini, et al.
Radiation Oncology (London, England)|July 10, 2021
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel diseaseJonathan W Lischalk, Seth Blacksburg, Christopher Mendez, et al.
Frontiers in Oncology|April 24, 2023
Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failureJustin Leu, Meredith Akerman, Christopher Mendez, et al.
Frontiers in Oncology|December 16, 2021
Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyNima Aghdam, Jonathan W Lischalk, Monica Pernia Marin, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Particle Therapy|July 1, 2022
Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal BalloonsMatthew Forsthoefel, Ryan Hankins, Elizabeth Ballew, et al.
Cancers|May 14, 2022
Return to Work, Fatigue and Cancer Rehabilitation after Curative Radiotherapy and Radiochemotherapy for Pelvic Gynecologic CancerEva Meixner, Elisabetta Sandrini, Line Hoeltgen, et al.
Clinical and Translational Radiation Oncology|March 6, 2023
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroidsEva Meixner, Juliane Hörner-Rieber, Jonathan W Lischalk, et al.
Radiation Oncology (London, England)|October 28, 2015
Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastasesJonathan W Lischalk, Eric Oermann, Sean P Collins, et al.
Frontiers in Oncology|April 24, 2023
Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failureJustin Leu, Meredith Akerman, Christopher Mendez, et al.
Frontiers in Oncology|March 15, 2021
Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate CancerNima Aghdam, Michael Carrasquilla, Edina Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 30, 2022
Iatrogenic influence on prognosis of radiation-induced contrast enhancements in patients with glioma WHO 1-3 following photon and proton radiotherapyTanja Eichkorn, Jonathan W Lischalk, Elisabetta Sandrini, et al.
Radiation Oncology (London, England)|July 10, 2021
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel diseaseJonathan W Lischalk, Seth Blacksburg, Christopher Mendez, et al.
Frontiers in Oncology|April 24, 2023
Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failureJustin Leu, Meredith Akerman, Christopher Mendez, et al.
Frontiers in Oncology|December 16, 2021
Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyNima Aghdam, Jonathan W Lischalk, Monica Pernia Marin, et al.
Pageof 8